News

The collaboration integrates cognitive computing capabilities of IBM Watson with Pfizer’s scientific know how to help scientists generate meaningful insights. Pfizer will be the first company to use

The acquisition is expected to expand the UK based Heptares’ intellectual assets and platform for structure-based drug design and development centred on G protein-coupled receptors (GPCRs). Considered to

The Natrix Protein A platform is expected to pave the way for a new generation of more flexible, highly-productive single-use based biologics production facilities for both batch and

Risankizumab is being evaluated in immunological disorders, including Crohn's disease, psoriasis, psoriatic arthritis and asthma. Risankizumab is an investigational treatment that is part of a collaboration between Boehringer

Evotec announced the signing of a set of collaboration agreements with the life science business of Merck, which will combine Merck's portfolio of genome editing technologies with Evotec's versatile

PF-05280014 demonstrated equivalence in objective response rate to Herceptin after 25 weeks of treatment in first line patients with HER2-positive metastatic breast cancer. The Reflections B3271002 is a

The company's decision follows the start of phase 3 clinical trial of the Tetravalent Immunization against Dengue Efficacy Study (TIDES), the global phase 3 clinical trial to assess the efficacy of a

The expansion is in response to customer demand for medical device manufacturing, especially in the area of diabetes, and represents West's most recent investment in Ireland, where the

The investment round is co-led by Life Sciences Partners, Netherlands, Ysios Capital, Spain, Sunstone Capital, Denmark, and Flerie Invest, Sweden, in addition to current shareholders Kurma Partners, France,